Aquablation

We are excited to be pioneering a truly game changing treatment for treating Benign Prostatic Hyperplasia (BPH) and Neil Barber has been involved in the trials of this unique and novel procedure.

Aquablation, delivered by PROCEPT BioRobotics™ AQUABEAM® System, uses a robotically controlled waterjet to remove prostate tissue without the application of heat.

The AquaBeam system is a first of its kind, image-guided system delivering a treatment utilizing water and robotics for the targeted removal of prostate tissue. AquaBeam combines image guidance and robotics to deliver Aquablation, a personalized waterjet tissue resection modality. Under real-time image-based ultrasonic guidance, AquaBeam enables surgical planning and mapping, and allows for a controlled resection of the prostate with a high-velocity saline stream. The combination of surgical mapping and controlled resection of the prostate is designed to offer predictable and reproducible outcomes.

Watch this video from PROCEPT for a step by step guide to Aquablation
 

Procept have recently released 6 month data from a unique global, double blind, randomized prospective study called WATER.

A summary of the reported findings of the WATER Study comparing Aquablation to TURP (current gold standard treatment) includes:

  • Significantly improved BPH symptoms in both treatment groups as measured by the International Prostate Symptom Score (IPSS) at six months with 100% of Aquablation patients improving from baseline
  • Superiority in IPSS storage symptom sub-scores (p<0.05)
  • Superiority in IPSS improvement with Aquablation in men with prostate volume greater than 50 ml as compared to TURP (p<0.01)
  • Superiority in peak urinary flow rates (Qmax) at six months
  • A significantly lower rate (4 to 1 ratio, p<0.001) of sexual side effects in Aquablation compared to TURP at three months
  • Superiority in ejaculatory function (MSHQ-EjD) and incontinence scores (ISI) at three months

In summary, the results are indicating outcomes like TURP and laser treatment but with a far lower risk of sexual dysfunction and speedier recovery. In fact rather than the expected 60 -70% chance of dry ejaculation seen with TURP or laser prostatectomies, aquablation using a non heat technique was associated with a 7% chance of dry ejaculation.

Neil Barber is the only surgeon in the world able to offer this treatment privately to self funding patients through the Phoenix Group of hospitals at Weymouth Street Hospital in London's Harley Street. To find out more details and to book a consultation with Neil, please contact his secretary here.

Neil is also carrying out trials for the procedure with patients at his NHS practice at Frimley Park hospital.